Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

Commit To Purchase Acadia Pharmaceuticals At $20, Earn 45.1% Annualized Using Options

Shutterstock photo

Investors eyeing a purchase of Acadia Pharmaceuticals Inc (Symbol: ACAD) shares, but tentative about paying the going market price of $23.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $20 strike, which has a bid at the time of this writing of $2.30. Collecting that bid as the premium represents a 11.5% return against the $20 commitment, or a 45.1% annualized rate of return (at Stock Options Channel we call this the YieldBoost ).

Selling a put does not give an investor access to ACAD's upside potential the way owning shares...